These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

627 related items for PubMed ID: 17468953

  • 1. Relationships between circulating hormone levels, mammographic percent density and breast cancer risk factors in postmenopausal women.
    Johansson H, Gandini S, Bonanni B, Mariette F, Guerrieri-Gonzaga A, Serrano D, Cassano E, Ramazzotto F, Baglietto L, Sandri MT, Decensi A.
    Breast Cancer Res Treat; 2008 Mar; 108(1):57-67. PubMed ID: 17468953
    [Abstract] [Full Text] [Related]

  • 2. The association of endogenous sex steroids and sex steroid binding proteins with mammographic density: results from the Postmenopausal Estrogen/Progestin Interventions Mammographic Density Study.
    Greendale GA, Palla SL, Ursin G, Laughlin GA, Crandall C, Pike MC, Reboussin BA.
    Am J Epidemiol; 2005 Nov 01; 162(9):826-34. PubMed ID: 16177147
    [Abstract] [Full Text] [Related]

  • 3. Factors associated with circulating levels of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in 740 women at risk for breast cancer.
    Johansson H, Baglietto L, Guerrieri-Gonzaga A, Bonanni B, Mariette F, Macis D, Serrano D, Sandri MT, Decensi A.
    Breast Cancer Res Treat; 2004 Nov 01; 88(1):63-73. PubMed ID: 15538047
    [Abstract] [Full Text] [Related]

  • 4. Endogenous sex hormones, prolactin and mammographic density in postmenopausal Norwegian women.
    Bremnes Y, Ursin G, Bjurstam N, Rinaldi S, Kaaks R, Gram IT.
    Int J Cancer; 2007 Dec 01; 121(11):2506-11. PubMed ID: 17657735
    [Abstract] [Full Text] [Related]

  • 5. Associations among circulating sex hormones, insulin-like growth factor, lipids, and mammographic density in postmenopausal women.
    Aiello EJ, Tworoger SS, Yasui Y, Stanczyk FZ, Potter J, Ulrich CM, Irwin M, McTiernan A.
    Cancer Epidemiol Biomarkers Prev; 2005 Jun 01; 14(6):1411-7. PubMed ID: 15941949
    [Abstract] [Full Text] [Related]

  • 6. Serum prolactin levels are positively associated with mammographic density in postmenopausal women.
    Greendale GA, Huang MH, Ursin G, Ingles S, Stanczyk F, Crandall C, Laughlin GA, Barrett-Connor E, Karlamangla A.
    Breast Cancer Res Treat; 2007 Nov 01; 105(3):337-46. PubMed ID: 17260098
    [Abstract] [Full Text] [Related]

  • 7. Elevated levels of circulating insulin-like growth factor-I, IGF-binding globulin-3 and testosterone predict hormone-dependent breast cancer in postmenopausal women: a case-control study.
    Kahán Z, Gardi J, Nyári T, Földesi I, Hajnal-Papp R, Ormándi K, Lázár G, Thurzó L, Schally AV.
    Int J Oncol; 2006 Jul 01; 29(1):193-200. PubMed ID: 16773200
    [Abstract] [Full Text] [Related]

  • 8. Inhibitory action on GHRH-induced GH secretion of chronic tamoxifen treatment in breast cancer.
    De Marinis L, Mancini A, Izzi D, Bianchi A, Giampietro A, Fusco A, Liberale I, Rossi S, Valle D.
    Clin Endocrinol (Oxf); 2000 Jun 01; 52(6):681-5. PubMed ID: 10848871
    [Abstract] [Full Text] [Related]

  • 9. Prenatal and perinatal correlates of adult mammographic breast density.
    Cerhan JR, Sellers TA, Janney CA, Pankratz VS, Brandt KR, Vachon CM.
    Cancer Epidemiol Biomarkers Prev; 2005 Jun 01; 14(6):1502-8. PubMed ID: 15941963
    [Abstract] [Full Text] [Related]

  • 10. A two-by-two factorial trial comparing oral with transdermal estrogen therapy and fenretinide with placebo on breast cancer biomarkers.
    Decensi A, Bonanni B, Baglietto L, Guerrieri-Gonzaga A, Ramazzotto F, Johansson H, Robertson C, Marinucci I, Mariette F, Sandri MT, Daldoss C, Bianco V, Buttarelli M, Cazzaniga M, Franchi D, Cassano E, Omodei U.
    Clin Cancer Res; 2004 Jul 01; 10(13):4389-97. PubMed ID: 15240527
    [Abstract] [Full Text] [Related]

  • 11. C-peptide, IGF-I, sex-steroid hormones and adiposity: a cross-sectional study in healthy women within the European Prospective Investigation into Cancer and Nutrition (EPIC).
    Bezemer ID, Rinaldi S, Dossus L, Gils CH, Peeters PH, Noord PA, Bueno-de-Mesquita HB, Johnsen SP, Overvad K, Olsen A, Tjønneland A, Boeing H, Lahmann PH, Linseisen J, Nagel G, Allen N, Roddam A, Bingham S, Khaw KT, Kesse E, Téhard B, Clavel-Chapelon F, Agudo A, Ardanaz E, Quiros JR, Amiano P, Martínez-Garcia C, Tormo MJ, Pala V, Panico S, Vineis P, Palli D, Tumino R, Trichopoulou A, Baibas N, Zilis D, Hémon B, Norat T, Riboli E, Kaaks R.
    Cancer Causes Control; 2005 Jun 01; 16(5):561-72. PubMed ID: 15986111
    [Abstract] [Full Text] [Related]

  • 12. Val158Met Polymorphism in catechol-O-methyltransferase gene associated with risk factors for breast cancer.
    Hong CC, Thompson HJ, Jiang C, Hammond GL, Tritchler D, Yaffe M, Boyd NF.
    Cancer Epidemiol Biomarkers Prev; 2003 Sep 01; 12(9):838-47. PubMed ID: 14504192
    [Abstract] [Full Text] [Related]

  • 13. A randomized, placebo-controlled trial (NCIC CTG MAP1) examining the effects of letrozole on mammographic breast density and other end organs in postmenopausal women.
    Cigler T, Tu D, Yaffe MJ, Findlay B, Verma S, Johnston D, Richardson H, Hu H, Qi S, Goss PE.
    Breast Cancer Res Treat; 2010 Apr 01; 120(2):427-35. PubMed ID: 19967558
    [Abstract] [Full Text] [Related]

  • 14. Effect of long-term treatment with raloxifene on mammary density in postmenopausal women.
    Lasco A, Gaudio A, Morini E, Morabito N, Nicita-Mauro C, Catalano A, Denuzzo G, Sansotta C, Xourafa A, Macrì I, Frisina N.
    Menopause; 2006 Apr 01; 13(5):787-92. PubMed ID: 16912660
    [Abstract] [Full Text] [Related]

  • 15. Plasma sex hormone concentrations and subsequent risk of breast cancer among women using postmenopausal hormones.
    Tworoger SS, Missmer SA, Barbieri RL, Willett WC, Colditz GA, Hankinson SE.
    J Natl Cancer Inst; 2005 Apr 20; 97(8):595-602. PubMed ID: 15840882
    [Abstract] [Full Text] [Related]

  • 16. Endogenous sex hormones, breast cancer risk, and tamoxifen response: an ancillary study in the NSABP Breast Cancer Prevention Trial (P-1).
    Beattie MS, Costantino JP, Cummings SR, Wickerham DL, Vogel VG, Dowsett M, Folkerd EJ, Willett WC, Wolmark N, Hankinson SE.
    J Natl Cancer Inst; 2006 Jan 18; 98(2):110-5. PubMed ID: 16418513
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Different effects of tibolone and continuous combined estrogen plus progestogen hormone therapy on sex hormone binding globulin and free testosterone levels--an association with mammographic density.
    Hofling M, Carlström K, Svane G, Azavedo E, Kloosterboer H, Von Schoultz B.
    Gynecol Endocrinol; 2005 Feb 18; 20(2):110-5. PubMed ID: 15823831
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.